Doris Steinemann, M. Dawidowska, Lisa J Russell, Christine J Harrison, Gudrun Göhring
{"title":"Genetic alterations in lymphoblastic leukaemia / lymphoma – a practical guide to WHO HAEM5","authors":"Doris Steinemann, M. Dawidowska, Lisa J Russell, Christine J Harrison, Gudrun Göhring","doi":"10.1515/medgen-2024-2007","DOIUrl":null,"url":null,"abstract":"\n We present a practical guide for analyzing the genetic aspects of lymphoblastic leukaemia/lymphoma according to the 5th edition of the World Health Organization (WHO) classification of haematolymphoid neoplasms (WHO-HAEM5) issued in 2024. The WHO-HAEM5 acknowledges the increasing importance of genetics in the diagnosis of lymphoid neoplasia. Classification is based on the established genetic subtypes according to cell lineage, with precursor cell neoplasms followed by mature malignancies. This guide describes those genetic abnormalities in acute precursor B- and T-cell neoplasms required for risk stratification, and for treatment, providing diagnostic algorithms under the headings of ‘essential’ and ‘desirable’ diagnostic criteria.","PeriodicalId":0,"journal":{"name":"","volume":"47 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1515/medgen-2024-2007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
We present a practical guide for analyzing the genetic aspects of lymphoblastic leukaemia/lymphoma according to the 5th edition of the World Health Organization (WHO) classification of haematolymphoid neoplasms (WHO-HAEM5) issued in 2024. The WHO-HAEM5 acknowledges the increasing importance of genetics in the diagnosis of lymphoid neoplasia. Classification is based on the established genetic subtypes according to cell lineage, with precursor cell neoplasms followed by mature malignancies. This guide describes those genetic abnormalities in acute precursor B- and T-cell neoplasms required for risk stratification, and for treatment, providing diagnostic algorithms under the headings of ‘essential’ and ‘desirable’ diagnostic criteria.
我们根据世界卫生组织（WHO）2024 年发布的第五版血液淋巴肿瘤分类（WHO-HAEM5），为分析淋巴母细胞白血病/淋巴瘤的遗传学问题提供了实用指南。WHO-HAEM5承认遗传学在淋巴肿瘤诊断中的重要性与日俱增。其分类依据的是根据细胞系确定的遗传亚型，先是前体细胞肿瘤，然后是成熟的恶性肿瘤。本指南描述了急性前体 B 细胞和 T 细胞肿瘤的基因异常，这些异常是进行风险分层和治疗所必需的，并在 "必要 "和 "理想 "诊断标准标题下提供了诊断算法。
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
